Bausch Market Capitalization from 2010 to 2025

BHC Stock  USD 7.70  0.16  2.12%   
Bausch Health's Market Cap is decreasing over the years with slightly volatile fluctuation. Market Cap is expected to dwindle to about 2.5 B.
Check Bausch Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 884.5 M, Interest Expense of 1.5 B or Selling General Administrative of 3.5 B, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 0.0522 or Days Sales Outstanding of 95.37. Bausch financial statements analysis is a perfect complement when working with Bausch Health Valuation or Volatility modules.
  
Check out the analysis of Bausch Health Correlation against competitors.

Latest Bausch Health's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Bausch Health Companies over the last few years. It is Bausch Health's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bausch Health's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.83 B10 Years Trend
Slightly volatile
   Market Cap   
34.85.0B7.3B6.5B2.9B2.6B2.5B-86%44%-11%-55%-10%-5%100%
       Timeline  

Bausch Market Capitalization Regression Statistics

Arithmetic Mean11,974,855,149
Geometric Mean5,233,125,024
Coefficient Of Variation124.85
Mean Deviation11,636,188,310
Median5,040,155,611
Standard Deviation14,950,652,491
Sample Variance223522009.9T
Range47.9B
R-Value(0.50)
Mean Square Error178560272.6T
R-Squared0.25
Significance0.05
Slope(1,583,913,928)
Total Sum of Squares3352830148.8T

Bausch Market Capitalization History

20252.5 B
20242.6 B
20192.9 B
20186.5 B
20177.3 B
2016B
201534.8 B

About Bausch Health Financial Statements

Bausch Health stakeholders use historical fundamental indicators, such as Bausch Health's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Bausch Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bausch Health's assets and liabilities are reflected in the revenues and expenses on Bausch Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bausch Health Companies. Please read more on our technical analysis and fundamental analysis pages.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. is headquartered in Laval, Canada. Bausch Health is traded on New York Stock Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out the analysis of Bausch Health Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Earnings Share
(0.13)
Revenue Per Share
26.155
Quarterly Revenue Growth
0.063
Return On Assets
0.0433
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

SHPH
Shuttle Pharmaceuticals
0.61  0.01  1.67 
TAK
Takeda Pharmaceutical
14.34  -0.02  -0.14 
EBS
Emergent Biosolutions
7.06  -0.21  -2.89 
ZTS
Zoetis Inc
164.98  -0.01  -0.0061 
TEVA
Teva Pharma Industries
16.32  -0.46  -2.74 
LFCR
Lifecore Biomedical
5.77  -0.2  -3.35 
PETQ
PetIQ Inc
0.00  0.00  0.00 
HLN
Haleon plc
9.79  -0.41  -4.02 
CTLT
Catalent
0.00  0.00  0.00 
NBIX
Neurocrine Biosciences
117.51  -0.08  -0.07 
VTRS
Viatris
9.53  -1.71  -15.21 
MNK
Mallinckrodt Plc
0.00  0.00  0.00 
LSDI
Lucy Scientific Discovery
0.00  0.00  0.00 
TLRY
Tilray Inc
0.76  -0.04  -5 
News Freq…Investor S…100%